Ticker > Company >

Sunrest Lifescience share price

Sunrest Lifescience Ltd.

NSE: SUNREST SECTOR: Trading  8.78 K   3   0

54.00
+10.35 (23.71%)
NSE: Today, 11:33 AM

Price Summary

Today's High

₹ 0

Today's Low

₹ 0

52 Week High

₹ 75

52 Week Low

₹ 38.5

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

23.17 Cr.

Enterprise Value

29.06 Cr.

No. of Shares

0.43 Cr.

P/E

11.59

P/B

1.43

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  37.72

CASH

0.28 Cr.

DEBT

6.16 Cr.

Promoter Holding

53.5 %

EPS (TTM)

₹  4.66

Sales Growth

12.34%

ROE

13.17 %

ROCE

13.63%

Profit Growth

786.04 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year12.34%
3 Year7.2%
5 Year24.77%

Profit Growth

1 Year786.04%
3 Year37.04%
5 Year122.35%

ROE%

1 Year13.17%
3 Year37.8%
5 Year61.02%

ROCE %

1 Year13.63%
3 Year26.19%
5 Year23.77%

Debt/Equity

0.3808

Price to Cash Flow

16.25

Interest Cover Ratio

9.6399

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2025 53.50 0.00
Jun 2025 69.91 0.00
Mar 2025 69.91 0.00
Dec 2024 69.91 0.00
Sep 2024 69.91 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 37.8029% over the past 3 years.
  • Company has been maintaining healthy ROCE of 26.1892666666667% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 9.6399.
  • Company’s PEG ratio is 0.0147416577896138.
  • The company has a high promoter holding of 53.5%.

 Limitations

  • The company has shown a poor revenue growth of 7.19885734832446% for the Past 3 years.
  • Company has high debtor days of 187.385.

Quarterly Result (All Figures in Cr.)

 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 16.95 26.89 24.64 29.48 33.12
Total Expenditure 16.67 25.78 21.74 28.58 30.12
Operating Profit 0.28 1.11 2.9 0.91 3
Other Income 0 0.02 0.03 0 0
Interest 0.01 0.02 0.06 0.22 0.3
Depreciation 0.04 0.06 0.13 0.1 0.09
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.22 1.05 2.74 0.59 2.61
Tax 0.06 0.27 0.7 0.37 0.61
Net Profit 0.17 0.78 2.04 0.23 2
Adjusted EPS (Rs.) 0.55 2.59 6.81 0.53 4.66

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 0.01 0.01 3 4.29 4.29
Total Reserves 0.28 1.06 0.11 9.89 11.89
Borrowings 2.28 3.09 2 3.46 4.08
Other N/C liabilities -0.01 -0.01 -0.02 -0.02 0.32
Current liabilities 6.91 8.86 11.6 7.51 14.55
Total Liabilities 9.47 13.01 16.7 25.13 35.13
Assets
Net Block 0.15 0.47 0.35 0.26 1.32
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0.02 0.02 5.52
Loans & Advances 0 0 0.03 0.03 0.03
Other N/C Assets 0 0 0 0 0
Current Assets 9.32 12.55 16.3 24.83 28.26
Total Assets 9.47 13.01 16.7 25.13 35.13
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 0.22 1.05 2.74 0.59 2.61
Adjustment 0.05 0.05 0.19 0.32 0.39
Changes in Assets & Liabilities -0.05 -1.47 -1.4 -14.87 -1.09
Tax Paid -0.07 -0.08 -0.38 -0.84 -0.48
Operating Cash Flow 0.15 -0.45 1.15 -14.8 1.43
Investing Cash Flow -0.16 -0.36 -0.03 -0.01 -1.14
Financing Cash Flow 0.04 0.91 -1.15 14.64 -0.3
Net Cash Flow 0.03 0.11 -0.03 -0.16 -0.01

Corporate Actions

Investors Details

PARTICULARS Sep 2024% Dec 2024% Mar 2025% Jun 2025% Sep 2025%
promoters 69.91 69.91 69.91 69.91 53.50
amitaben amitkumar thakka... 0.02 0.02 0.02 0.02 0.02
amitbhai shambhulal thakk... 17.45 17.45 17.45 17.45 13.35
bhagyesh kiritbhai parekh... 15.73 15.73 15.73 15.73 11.63
bharatkumar vardhilal tha... 15.73 15.73 15.73 15.73 11.63
meha bhagyesh parekh 1.75 1.75 1.75 1.75 1.75
nikhilkumar yashvntlal th... 17.48 17.48 17.48 17.48 13.38
sonalben bharatkumar thak... 1.75 1.75 1.75 1.75 1.75
PARTICULARS Sep 2024% Dec 2024% Mar 2025% Jun 2025% Sep 2025%
investors 30.09 30.09 30.09 30.09 46.50
amit r agarwal - - - - 3.95
comely electrical private... - - - - 1.86
khushboo ashish jain - - - - 1.49
manju devi 1.16 1.16 1.16 1.16 1.16
pooja rahul shah - - - - 1.83
prakash gourisankar jhunj... - - - - 3.13
rikhav securities limited... - - - - 1.68
shardaben dalsukhram thak... 1.49 1.49 1.49 1.49 1.49
ashok ramchandra mittal h... 1.04 1.01 - - -

Annual Reports

Title Link
Title Link
Annual Report 2025
Annual Report 2024

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Sunrest Lifescience Stock Price Analysis and Quick Research Report. Is Sunrest Lifescience an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Sunrest Lifescience. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Sunrest Lifescience has a PE ratio of 9.36655079181151 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Sunrest Lifescience has ROA of 6.6365% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Sunrest Lifescience has a Current ratio of 1.9426.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Sunrest Lifescience has a ROE of 13.1693%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Sunrest Lifescience has a Debt to Equity ratio of 0.3808 which means that the company has low proportion of debt in its capital.

  • Sales growth: Sunrest Lifescience has reported revenue growth of 12.3444% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Sunrest Lifescience for the current financial year is 9.0573146873415%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Sunrest Lifescience is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Sunrest Lifescience is Rs 4.6602. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Sunrest Lifescience in Ticker for free. Also, one can get the intrinsic value of Sunrest Lifescience by using Valuation Calculators, which are available with a Finology ONE subscription. 

Sunrest Lifescience FAQs

Q1. What is Sunrest Lifescience share price today?
Ans: The current share price of Sunrest Lifescience is Rs 43.65.

Q2. What is the market capitalisation of Sunrest Lifescience?
Ans: Sunrest Lifescience has a market capitalisation of Rs 18.731088 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Sunrest Lifescience?
Ans: The PE ratio of Sunrest Lifescience is 9.36655079181151 and the P/B ratio of Sunrest Lifescience is 1.15729693614584, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Sunrest Lifescience share?
Ans: The 52-week high share price of Sunrest Lifescience is Rs 75, and the 52-week low share price of Sunrest Lifescience is Rs 40.15.

Q5. Does Sunrest Lifescience pay dividends?
Ans: Currently, Sunrest Lifescience does not pay dividends. Dividend yield of Sunrest Lifescience is around 0%.

Q6. What are the face value and book value of Sunrest Lifescience shares?
Ans: The face value of Sunrest Lifescience shares is Rs 10, while the book value per share of Sunrest Lifescience is around Rs 37.7172. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Sunrest Lifescience?
Ans: Sunrest Lifescience has a total debt of Rs 6.1629 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Sunrest Lifescience?
Ans: The ROE of Sunrest Lifescience is 13.1693% and ROCE of Sunrest Lifescience is 13.6336%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Sunrest Lifescience a good buy for the long term?
Ans: The Sunrest Lifescience long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Sunrest Lifescience undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Sunrest Lifescience appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Sunrest Lifescience’s financials?
Ans: You can review Sunrest Lifescience’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Sunrest Lifescience
X